Breaking News Instant updates and real-time market news.

CYH

Community Health

$6.33

0.025 (0.40%)

, HCA

HCA Holdings

$78.40

-0.52 (-0.66%)

15:03
01/10/17
01/10
15:03
01/10/17
15:03

Trump presses for immediate repeal, replace of Obamacare, NYT says

Donald Trump on Tuesday pushed lawmakers for a nearly immediate repeal of Obamacare, the New York Times reported, citing statements from the President-elect. Trump demanded a repeal vote "probably some time next week," adding that "the replace will be very quickly or simultaneously, very shortly thereafter... It won't be repeal and then two years later go in with another plan," according to the report. The publication argues that the request is "very likely impossible," as lawmakers are "nowhere close" to agreeing on a replacement. The publication also notes that the request is in clear contradiction of Speaker Paul Ryan's plans. Publicly traded companies in the hospital and healthcare space include Community Health Systems (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC), Universal Health Services (UHS), UnitedHealth (UNH), Kindred (KND) and Ventas (VTR). Reference Link

CYH

Community Health

$6.33

0.025 (0.40%)

HCA

HCA Holdings

$78.40

-0.52 (-0.66%)

LPNT

LifePoint

$59.90

0.8 (1.35%)

THC

Tenet

$17.53

0.28 (1.62%)

UHS

Universal Health

$112.41

0.87 (0.78%)

UNH

UnitedHealth

$161.90

-0.05 (-0.03%)

KND

Kindred Healthcare

$7.90

-0.1 (-1.25%)

VTR

Ventas

$61.26

-2.19 (-3.45%)

  • 10

    Jan

  • 17

    Jan

  • 10

    Feb

CYH Community Health
$6.33

0.025 (0.40%)

11/11/16
FBCO
11/11/16
DOWNGRADE
FBCO
Underperform
Community Health downgraded to Underperform from Neutral at Credit Suisse
11/11/16
FBCO
11/11/16
DOWNGRADE
Target $4.25
FBCO
Underperform
Community Health downgraded Underperform on ACA risk at Credit Suisse
As previously reported, Credit Suisse downgraded Molina to Underperform from Neutral and lowered its price target to $4.25 from $7. Analyst Scott Fidel changed his raiting to reflect Affordable Care Act repeal risk and industry high margin profile.
01/03/17
PIPR
01/03/17
INITIATION
Target $6
PIPR
Neutral
Community Health initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Community Health with a Neutral and a $6 price target.
12/23/16
LEER
12/23/16
NO CHANGE
LEER
Market Perform
Community Health real estate transaction a 'modest positive,' says Leerink
Leerink analyst Ana Gupte views Community Health's sale and leaseback of ten medical office buildings as a "modest positive." The analyst remains on the sidelines despite the recent selloff given the weaker visibility into the operational outlook, as well as the EBITDA and timing of divestitures. She reiterates a Market Perform rating on the shares.
HCA HCA Holdings
$78.40

-0.52 (-0.66%)

11/09/16
AVON
11/09/16
DOWNGRADE
AVON
Market Perform
HCA Holdings downgraded to Market Perform from Outperform at Avondale
01/03/17
PIPR
01/03/17
INITIATION
Target $81
PIPR
Overweight
HCA Holdings initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sarah James initiated HCA Holdings with an Overweight and an $81 price target.
11/09/16
MZHO
11/09/16
DOWNGRADE
Target $78
MZHO
Neutral
HCA Holdings downgraded to Neutral on Republican win at Mizuho
As previously reported, Mizuho analyst Sheryl Skolnick downgraded HCA Holdings to Neutral from Buy citing Donald Trump's election and the move to a GOP Congress. Following the election results, Skolnick sees an "extreme risk" for the ACA to be repealed and replaced and for the loss of the Medicaid expansion, both of which she notes have been primary drivers of results for hospitals and health plans. She cut her price target on the stock to $78 from $97.
11/15/16
UBSW
11/15/16
NO CHANGE
Target $90
UBSW
Buy
HCA Holdings share buybacks a strong positive signal, says UBS
UBS analyst A.J. Rice said HCA sent a strong positive signal with its authorization of an additional share repurchase program for up to $2B and he recommends focusing on HCA within the Hospital group while waiting for clarity on ACA in the wake of the election. Rice, who citing HCA's margins, above average growth, cash flow, share repurchases and below average exposure to ACA, keeps a Buy rating and $90 price target on the stock.
LPNT LifePoint
$59.90

0.8 (1.35%)

01/03/17
PIPR
01/03/17
INITIATION
Target $62
PIPR
Neutral
LifePoint initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated LifePoint with a Neutral and a $62 price target.
11/11/16
FBCO
11/11/16
DOWNGRADE
Target $60
FBCO
Neutral
LifePoint downgraded to Neutral following Trump win at Credit Suisse
As previously reported, Credit Suisse downgraded LifePoint to Neutral from Outperform and lowered its price target to $60 from $70. Analyst Scott Fidel said LifePoint has significantly benefited from the Affordable Care Act and sees significant uncertainty ahead following Trump's victory and the Republican sweep. The analyst said 8%-10% of LifePoint's EBITDA could be at risk, which could be partially offset by improvements at its recently acquired facilities.
11/09/16
AVON
11/09/16
DOWNGRADE
AVON
Market Perform
LifePoint downgraded to Market Perform from Outperform at Avondale
11/11/16
FBCO
11/11/16
DOWNGRADE
FBCO
Neutral
LifePoint downgraded to Neutral from Outperform at Credit Suisse
THC Tenet
$17.53

0.28 (1.62%)

11/10/16
11/10/16
DOWNGRADE

Market Perform
Tenet downgraded to Market Perform at Raymond James
As previously reported, Raymond James downgraded Tenet to Market Perform from Outperform. The firm's analyst said Tenet's valuation appears to be pricing in a "repeal" of ACA while forgetting the "replace" aspect and notes there is not sufficient detail on what Trump's policy proposals on healthcare will look like yet.
11/10/16
RAJA
11/10/16
DOWNGRADE
RAJA
Market Perform
Tenet downgraded to Market Perform from Outperform at Raymond James
01/03/17
PIPR
01/03/17
INITIATION
Target $16
PIPR
Neutral
Tenet initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Tenet with a Neutral and a $16 price target.
11/22/16
MZHO
11/22/16
DOWNGRADE
MZHO
Underperform
Tenet downgraded to Underperform from Neutral at Mizuho
Mizuho downgraded Tenet to Underperform citing premium valuation and lack of visibility on what will happen to ACA, Medicaid, and Medicare.
UHS Universal Health
$112.41

0.87 (0.78%)

01/03/17
PIPR
01/03/17
INITIATION
Target $119
PIPR
Neutral
Universal Health initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James initiated Universal Health with a Neutral and a $119 price target..
12/14/16
12/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) downgraded to Neutral from Overweight at JPMorgan with analyst Rod Hall saying the shares are near fair value while the global consumer picture "remains negative." 2. Prudential (PRU) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Nigel Dally saying he recommends taking some profits following the post election surge. 3. Proteon Therapeutics (PRTO) downgraded to Neutral from Outperform at Baird, to Perform from Outperform at Oppenheimer, to Market Perform at JMP Securities, to Hold from Buy at Stifel, to Market Perform at Raymond James, and to Market Perform from Outperform at Cowen. 4. Universal Health (UHS) downgraded to Market Perform from Outperform at Raymond James with analyst John Ransom saying he sees increasing political risk following Senator Grassley's letter to the inspector general regarding details of the current federal investigation into Universal Health and thinks it's possible that increased political scrutiny could result in more caution and/or red tape into the admissions process, either from self-policing or externally. 5. Lincoln National (LNC) downgraded to Equal Weight from Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/14/16
12/14/16
DOWNGRADE

Market Perform
Universal Health downgraded on increased political risk at Raymond James
As previously reported, Raymond James downgraded Universal Health to Market Perform from Outperform. Analyst John Ransom sees increasing political risk following Senator Grassley's letter to the inspector general regarding details of the current federal investigation into Universal Health and thinks it's possible that increased political scrutiny could result in more caution and/or red tape into the admissions process, either from self-policing or externally.
12/14/16
RAJA
12/14/16
DOWNGRADE
RAJA
Market Perform
Universal Health downgraded to Market Perform from Outperform at Raymond James
UNH UnitedHealth
$161.90

-0.05 (-0.03%)

01/03/17
PIPR
01/03/17
INITIATION
Target $188
PIPR
Overweight
UnitedHealth initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Sarah James commenced co-coverage on UnitedHealth with an Overweight and a $188 price target, up from $155. Piper Jaffray's Healthcare IT Sr. Analyst, Sean Wieland, will continue to focus on Optum while James will provide a refreshed look at the managed care portion. James believes UnitedHealth will grow earnings above peers driven by capital deployment, best in class cost control, which drives market share gains, international expansion, and above consensus growth in Optum as it builds out relationships with existing customers and increasingly beats large peers on new contract wins.
12/23/16
JEFF
12/23/16
NO CHANGE
Target $89
JEFF
Buy
Jefferies expects Magellan to rally today on Virginia win
Jefferies analyst David Styblo expects shares of Magellan Health (MGLN) to rally today on the news that the company was one of seven managed care organizations selected for the $3.5B Virginia Managed Long Term Services and Supports initiative. Besides the financial benefit, the award shows Magellan can compete for business serving acute populations, Styblo tells investors in a research note titled "Santa Delivers Early for MGLN in Virginia." The other six winners include Aetna (AET), Anthem (ANTM), Humana (HUM), UnitedHealth (UNH), Optima Health and Virginia Premier, the analyst notes. Styblo reiterates a Buy rating on Magellan with an $89 price target.
12/01/16
FBCO
12/01/16
NO CHANGE
FBCO
Outperform
UnitedHealth policy for Exondys 51 a positive for Sarepta, says Credit Suisse
Credit Suisse analyst Alethia Young noted that Sarepta (SRPT) shares have been weak since UnitedHealth (UNH) posted its medical benefit policy for the company's DMD drug Exondys 51, but she doesn't see a reason for the weakness. She doesn't think encouraging home infusions limits access and believes the requirement for an every 6 month reauthorization is neither "prohibitive nor concerning" as it is standard with expensive rare disease treatments. She sees the policy as a positive for Sarepta, as having more payers supporting Exondys reimbursement makes it hard for other payers not to do so, and keeps an Outperform rating on Sarepta shares.
12/07/16
CANT
12/07/16
UPGRADE
CANT
Buy
UnitedHealth upgraded to Buy from Hold at Cantor
KND Kindred Healthcare
$7.90

-0.1 (-1.25%)

11/08/16
STFL
11/08/16
DOWNGRADE
STFL
Sell
Kindred Healthcare downgraded on Q3 miss, guidance cut at Stifel
As noted earlier, Stifel downgraded Kindred to Sell from Hold. Analyst Chad Vanacore downgraded the stock based on the company's weaker than expected results and guidance reduction. Target to $5 from $10.
11/08/16
STFL
11/08/16
DOWNGRADE
STFL
Sell
Kindred Healthcare downgraded to Sell from Hold at Stifel
11/10/16
RBCM
11/10/16
DOWNGRADE
RBCM
Sector Perform
Kindred Healthcare downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Frank Morgan downgraded Kindred after the company lowered its fiscal 2016 guidance. Morgan says that the guidance cut was caused by pressures on the company's SNF segment. Morgan adds that the company's planned exit from its SNF business, along with regulatory pressures, will produce "significant uncertainties and likely bumpiness." He thinks that the stock could rebound in the near-term, but he expects it to subsequently be "range-bound" for "the next year or so." Target to $9 from $16.
VTR Ventas
$61.26

-2.19 (-3.45%)

11/21/16
MZHO
11/21/16
DOWNGRADE
MZHO
Neutral
Ventas downgraded to Neutral from Buy at Mizuho
11/10/16
BMOC
11/10/16
DOWNGRADE
BMOC
Underperform
Ventas downgraded on Trump victory at BMO Capital
As noted earlier, BMO Capital downgraded Ventas to Underperform from Market Perform. Analyst John Kim says that the expected repeal of the ACA will hurt hospitals and consequently medical office building demand. The analyst says that Ventas has high exposure to the latter. Target $55.
11/11/16
HDLY
11/11/16
UPGRADE
HDLY
Neutral
Ventas upgraded to Neutral from Underperform at Hilliard Lyons
01/03/17
JEFF
01/03/17
DOWNGRADE
Target $65
JEFF
Hold
Ventas downgraded to Hold from Buy at Jefferies
Jefferies analyst Omotayo Okusanya downgraded Ventas to Hold saying potential repeal of the Affordable Care Act creates headwinds for the company's hospital portfolio. Rising interest rates are also an additional headwind, the analyst contends. He views a Trump presidency as bad for hospitals and lowered his price target for Ventas shares to $65 from $75.

TODAY'S FREE FLY STORIES

FB

Facebook

$153.91

1.66 (1.09%)

12:22
06/22/17
06/22
12:22
06/22/17
12:22
Hot Stocks
Facebook holds communities event, announces new mission »

Facebook hosted its first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

FLR

Fluor

$44.29

0.52 (1.19%)

12:20
06/22/17
06/22
12:20
06/22/17
12:20
Options
Flour calls seeing opening interest »

Flour calls seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
06/22/17
06/22
12:17
06/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
06/22/17
06/22
12:16
06/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

12:10
06/22/17
06/22
12:10
06/22/17
12:10
Options
Notable call buying in Canadian Solar as shares shine »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
06/22/17
06/22
12:10
06/22/17
12:10
General news
Treasury Option Action: a call 1x2 on 10s »

Treasury Option Action: a…

SRSC

Sears Canada

$0.47

-0.115 (-19.69%)

12:05
06/22/17
06/22
12:05
06/22/17
12:05
Hot Stocks
Breaking Hot Stocks news story on Sears Canada »

Sears Canada trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

, GOOG

Alphabet

$959.45

8.82 (0.93%)

12:01
06/22/17
06/22
12:01
06/22/17
12:01
Hot Stocks
Nielsen launches mobile measurement for YouTube ads »

Nielsen (NLSN) announced…

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

GOOG

Alphabet

$959.45

8.82 (0.93%)

GOOGL

Alphabet Class A

$978.59

9.6 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AKS

AK Steel

$6.25

0.055 (0.89%)

12:00
06/22/17
06/22
12:00
06/22/17
12:00
Options
AK Steel Jul 8 calls are today's most active option »

AK Steel Jul 8 calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CVM

CEL-SCI

$1.75

0.0576 (3.41%)

11:58
06/22/17
06/22
11:58
06/22/17
11:58
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI 

Cel Sci trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

11:55
06/22/17
06/22
11:55
06/22/17
11:55
Hot Stocks
Hain Celestial CEO says he has a strong management team backing him »

The Hain Celestial CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

11:53
06/22/17
06/22
11:53
06/22/17
11:53
Hot Stocks
Hain Celestial says Amazon deal for Whole Foods will give more exposure »

The Hain Celestial CEO is…

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

WFM

Whole Foods

$43.26

0.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

  • 28

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

11:47
06/22/17
06/22
11:47
06/22/17
11:47
Recommendations
Staples analyst commentary  »

Staples intrinsic value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$36.80

-0.2 (-0.54%)

11:46
06/22/17
06/22
11:46
06/22/17
11:46
Recommendations
Merit Medical analyst commentary  »

Merit Medical allowance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FSLR

First Solar

$37.23

1.78 (5.02%)

11:45
06/22/17
06/22
11:45
06/22/17
11:45
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change  »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$18.47

0.06 (0.33%)

11:38
06/22/17
06/22
11:38
06/22/17
11:38
Hot Stocks
Breaking Hot Stocks news story on Commercial Metals »

Commercial Metals says a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LPNT

LifePoint

$64.85

0.25 (0.39%)

, CYH

Community Health

$9.56

0.74 (8.39%)

11:35
06/22/17
06/22
11:35
06/22/17
11:35
Hot Stocks
Hosptial stocks at highs after Republicans release ACHA 'discussion draft' »

Publicly traded companies…

LPNT

LifePoint

$64.85

0.25 (0.39%)

CYH

Community Health

$9.56

0.74 (8.39%)

THC

Tenet

$18.94

1.26 (7.13%)

HCA

HCA Holdings

$87.44

3.39 (4.03%)

UHS

Universal Health

$116.28

3.06 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$38.27

0.85 (2.27%)

11:26
06/22/17
06/22
11:26
06/22/17
11:26
Periodicals
Mylan investors vote against executive pay, re-elect board members, Reuters says »

Mylan shareholders voted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 13

    Jul

  • 03

    Sep

  • 09

    Oct

11:25
06/22/17
06/22
11:25
06/22/17
11:25
General news
Treasury announced an $88 B package of coupon offerings for next week »

Treasury announced an $88…

V

Visa

$94.25

-0.29 (-0.31%)

11:23
06/22/17
06/22
11:23
06/22/17
11:23
Hot Stocks
Breaking Hot Stocks news story on Visa »

Visa says 'engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

KR

Kroger

$22.12

-0.2542 (-1.14%)

11:21
06/22/17
06/22
11:21
06/22/17
11:21
Hot Stocks
Kroger board approves $1B share repurchase program, raises quarterly dividend »

The Kroger Co.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

V

Visa

$94.21

-0.33 (-0.35%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Hot Stocks
Visa says continues to pursue domestic license in China »

Says regulation a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

BAC

Bank of America

$23.02

-0.115 (-0.50%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Options
Big block of BofA calls as shares dip »

Big block of BofA calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$18.43

0.0192 (0.10%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Hot Stocks
Commercial Metals says Q4 is usually a strong shipping quarter »

Sees Q4 margins stable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.